Type 1 diabetes mellitus (T1DM) is one of the most challenging medical disorders, and one of the key therapeutic goals to prevent or delay long-term diabetes complications in T1DM is the achievement and maintenance of near-normal glycemic control 1 . Only insulin treatment is not enough to rely on, dietary adjustments also play an important role in the regulation of blood glucose. Carbohydrates are a major determinant of postprandial blood glucose. Carbohydrate counting is a meal planning approach used with clients who have diabetes that focuses on carbohydrate as the primary nutrient affecting postprandial glycemic response. Advanced carbohydrate counting allows adjustment of the prandial insulin dose for actual carbohydrate intake in T1DM patients on intensive insulin therapy. Therefore, by calculating the carbohydrate amounts in each meal, insulin doses required to preserve postprandial blood glucose within normal limits can be predicted 2, 3 . The current guidelines recommend that the algorithms for prandial insulin calculation take into account the carbohydrate amount of the meal 4 . However, the efficacy of carbohydrate counting is not fully understood. At present, study to inquiry the effect of carbohydrate counting on T1DM patients is relatively little. Evidence from randomized controlled trials (RCTs) reported inconsistent results [5] [6] [7] . Previous systematic review 8 or meta-analysis 9 did not cite a clear conclusion. Furthermore, three recent trials 10-12 with adequate power have been published and involve new evidence. Therefore, we performed this meta-analysis to evaluate the efficiency of carbohydrate counting on glycemic control in people with T1DM.
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Methods
Literature search. This study was conducted following the Cochrane Collaboration and the PRISMA The search strategy included following terms: "carbohydrate counting", "Type 1 diabetes mellitus", "Glycated hemoglobin" and "HbA lc " (an example of specific strategy is shown in Supplementary material: Table S1 ). We read titles and abstracts of retrieved records to eliminate studies those were clearly irrelevant, and read full text of all remaining articles to decide eligible studies. Those discrepancies were resolved by discussion and consensus. Reference lists of identified trials and review articles were also hand-screened to identify any other relevant studies.
Eligility criteria. Trials satisfying the following criteria were included: (1) design: randomised and quasi-randomised controlled clinical trials with at least 3 months' follow-up; (2) population: T1DM who had injected insulin a minimum of three months; (3) intervention: carbohydrate counting versus other diabetes diet method or usual diabetes dietary education; (4) data: adequate information provided to calculate the standardized mean difference (SMD) and the corresponding 95% confidence interval (CI). We did not use any language limitations. Pregnant women with T1DM also be included in this study.
Data extraction.
Data was extracted and placed into a spreadsheet from each included study. The following information was collected: first author, year of publication, country of origin, number of patients, intervention, control, outcomes data (glycosylated hemoglobin (HbA lc ) (%), hypoglycemia events, insulin dose and body mass index (BMI)) and follow up. We also contacted corresponding authors to verify extracted data and to request the missing data. The change in HbA 1c concentration was predefined primary outcome, and secondary outcomes were the change in hypoglycemia events, insulin dose and BMI. Risk of bias assessment. Risk of bias was assessed by using the Cochrane Collaboration's tool 15 . Each study was assessed and scored as "high", "low", or "unclear" risk of bias to the following criteria: random sequence generation; allocation concealment; blinding of participants and personnel; blinding of outcome assessment; incomplete outcome data; selective reporting; and other bias. Blinding of patients and clinicians was extremely difficult and generally not feasible in these trials, and we judged that the primary outcome was less prone to be influenced by lack of blinding. Therefore, studies with high risk of bias for any one or more key domains except blinding were considered as at high risk of bias; while studies with low risk of bias for all key domains except blinding were considered as at low risk of bias; otherwise they were considered as at unclear risk of bias.
Quality of evidence assessment. The quality of evidence for primary and secondary outcomes was assessed according to GRADE methodology for risk of bias, inconsistency, indirectness, imprecision, and publication bias; classified as high, moderate, low or very low. Summary tables were constructed by the GRADE system [16] [17] [18] [19] (GRADE version 3.6). The literature search, data extraction, risk of bias assessment and evidence grade assessment were done independently by two authors (SF and LL) using a same approach. Disagreements were resolved by discussion among all authors.
Statistical analysis. Since all the observation indexes are continuous, and the measurement time of outcome is inconsistent in different studies, thus we pooled the SMD with corresponding 95% CI by using the random-effects model. Heterogeneity across studies was explored by using the I 2 statistic 20 (the I 2 > 50% indicated significant heterogeneity), and publication bias was assessed by using Begg's test and Egger's test (P < 0.05 was considered statistically significant for publication bias). Sensitivity analysis was conducted to investigate the stability and reliability of results. met the inclusion criteria. While one of them was excluded due to lack of essential data, and we failed to get the raw data from original author 25 . One more article 24 from reference lists of identified trials also met the inclusion criteria and was included in this study. Totally 10 articles were included in the meta-analysis, the literature review process was showed in Fig. 1 . According to the Cochrane Collaboration's tool, two trials 9, 24 were categorized as at low risk of bias, five as at unclear 5, 6, 10, 12, 21 , and three as at high risk of bias 7, 11, 23 . All details of the risk of bias are supplied in Figs 2 and 3.
Characteristics of articles. These ten studies involving 773 participants were published from 2000 to 2014. Four studies 5, 7, 10, 12 enrolled children and adolescents, and the remaining six studies included adults 6, 11, [21] [22] [23] [24] . Among ten included studies, five compared the carbohydrate counting with other diabetes diet method [5] [6] [7] 11, 12 , and the remaining five compared the carbohydrate counting with usual diabetes dietary education 10, [21] [22] [23] [24] . All studies reported changes in HbA 1c concentration, four studies 5, 7, 12, 21 reported changes in daily insulin dosage, three studies 5, 22, 24 reported changes in hypoglycemia event frequency and two studies 7, 21 reported changes in BMI. Detailed characteristics of eligible studies were provided in Table 1 . Figure S1 ).
Secondary outcomes.
Secondary outcomes including the change in hypoglycemia events, insulin doses and BMI. There are four studies 5, 7, 12, 21 reported insulin doses, while the data one study reported was suspectable 21 , and we failed to obtain raw data from authors. Thus it was excluded and three studies were included in the meta-analysis. There are three studies 5, 22, 24 reported hypoglycemia events and three reported BMI data 7, 21 , respectively. Compared with other diabetes diet method or usual diabetes dietary education, carbohydrate counting did not significantly reduce the hypoglycaemia events (SMD: − 0.14, 95%CI: − 0.39 to 0.10, P = 0.254; I 2 = 0.0%, Scientific RepoRts | 6:37067 | DOI: 10.1038/srep37067 P = 0.758), insulin dosage (SMD: 0.04, 95%CI: − 0.24 to 0.31, P = 0.788; I 2 = 0.0%, P = 0.945) or BMI (SMD: − 0.06, 95%CI: − 0.39 to 0.28, P = 0.749; I 2 = 0.0%, P = 0.328) (Fig. 6) .
Strength of evidence and publication bias. The quality of evidences was evaluated by GRADE system. Comparison with previous meta-analysis. In our study, the effect of carbohydrate counting reducing HbA 1c concentration is consistent with previous meta-analysis 11 . While differences between our study and previous analysis should be noted. First, previous meta-analysis included seven trials totaling 703 participants. We included six of the seven trials, the other one was excluded due to lack of essential data, and we failed to get the raw data from authors. While we added four new trials, and we also added subgroup analysis according to the control group, got a more stable and reliable conclusion by eliminating interference factors. Our meta-analysis found that heterogeneity among trials mainly is from the design of different control group, rather than population. In addition, we evaluated the quality of evidence and the strength of recommendations. Therefore, our current meta-analysis was the latest and the most comprehensive one.
Guidance for clinical practice. First, our study found that carbohydrate counting has a positive effect on reducing HbA 1c concentration. This effect is stable and reliable, and carbohydrate counting should be recommended for the routine treatment of T1DM. Second, up to now, little attention was paid to the study of carbohydrate counting's effect on hypoglycemia events, insulin doses and BMI. The impact of carbohydrate counting on these aspects is a direction of future research. Finally, considering the dietary education in a more general sense may exaggerate the effect of carbohydrate counting, more clinical trials compared carbohydrate counting with dietary education in a more general sense are warranted to validate the positive impact of carbohydrate counting.
Limitations. Our study also has limitations. Though high quality of studies included in this meta-analysis, the sample sizes of these studies are small, and there is significant heterogeneity among studies, the reliability of results can be affected. More high quality trials with large samples are needed to confirm current results.
Conclusion
Our meta-analysis suggested that carbohydrate counting plays an important role in reducing HbA 1c concentration, and this positive impact still needs evaluation by high-quality randomly controlled experiments.
